Fig. 8
From: Macrophage mitophagy-related genes predict prognosis and therapeutic response in lung adenocarcinoma
Construction and validation of the LUAD prognostic risk model. (A) M-Cox analysis confirming TUBB6 and CAT as independent prognostic indicators, and used to build a LUAD risk scoring model. (B) TCGA-LUAD training set: Kaplan-Meier survival analysis, risk score distribution, gene expression heatmap, and time-dependent ROC curves evaluating model performance. (C) GSE68465 validation cohort: Survival curves, risk stratification, expression profiles, and ROC analysis demonstrating model robustness. (D) GSE13213 validation cohort: Time-dependent ROC and survival analysis confirming the prognostic value of the model in an independent dataset.
